CA2009221A1 - Spray preparations for respiratory tract infections - Google Patents

Spray preparations for respiratory tract infections

Info

Publication number
CA2009221A1
CA2009221A1 CA2009221A CA2009221A CA2009221A1 CA 2009221 A1 CA2009221 A1 CA 2009221A1 CA 2009221 A CA2009221 A CA 2009221A CA 2009221 A CA2009221 A CA 2009221A CA 2009221 A1 CA2009221 A1 CA 2009221A1
Authority
CA
Canada
Prior art keywords
respiratory tract
tract infections
spray preparations
zinc
spray
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2009221A
Other languages
French (fr)
Other versions
CA2009221C (en
Inventor
Derek Bryce-Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kappa Pharmaceuticals Ltd
Original Assignee
Derek Bryce-Smith
Alpha Healthcare Limited
Kappa Pharmaceutical Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Derek Bryce-Smith, Alpha Healthcare Limited, Kappa Pharmaceutical Limited filed Critical Derek Bryce-Smith
Publication of CA2009221A1 publication Critical patent/CA2009221A1/en
Application granted granted Critical
Publication of CA2009221C publication Critical patent/CA2009221C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Abstract

The present invention provides a simple, cheap and efficient cure for the common cold, and comprises a nasal spray of a dilute solution of substantially unchelated zinc ion, especially zinc sulphate and/or zinc chloride.
CA002009221A 1989-02-02 1990-02-02 Spray preparations for respiratory tract infections Expired - Fee Related CA2009221C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8902300.6 1989-02-02
GB898902300A GB8902300D0 (en) 1989-02-02 1989-02-02 Antirhinoviral preparations

Publications (2)

Publication Number Publication Date
CA2009221A1 true CA2009221A1 (en) 1990-08-02
CA2009221C CA2009221C (en) 2000-10-17

Family

ID=10651009

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002009221A Expired - Fee Related CA2009221C (en) 1989-02-02 1990-02-02 Spray preparations for respiratory tract infections

Country Status (11)

Country Link
US (1) US5622724A (en)
EP (1) EP0381522B1 (en)
JP (1) JPH03197430A (en)
AT (1) ATE132747T1 (en)
AU (1) AU652337B2 (en)
CA (1) CA2009221C (en)
DE (1) DE69024672T2 (en)
ES (1) ES2080787T3 (en)
GB (1) GB8902300D0 (en)
IE (1) IE71664B1 (en)
NZ (1) NZ232356A (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8916625D0 (en) * 1989-07-20 1989-09-06 Bryce Smith Derek Respiratory tract spray preparations
DE4205828A1 (en) * 1992-02-26 1993-09-02 Henkel Kgaa VIRUSIVE DISINFECTANT
US5897872A (en) * 1997-11-12 1999-04-27 Picciano; Dante J. Iodine-containing nasal moisturizing saline solution
US6171611B1 (en) 1997-11-12 2001-01-09 Dante J. Picciano Iodine-containing nasal moisturizing saline and mouthwash solutions
ES2136033B1 (en) * 1997-12-10 2000-05-16 Tudela Bernardo Hernandez PRODUCT AGAINST COLD WITH ZINC COMPOUNDS
GB9806937D0 (en) 1998-03-31 1998-05-27 Procter & Gamble A spray device
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
US20040234457A1 (en) * 1999-10-19 2004-11-25 The Procter & Gamble Company Methods of preventing and treating SARS using low pH respiratory tract compositions
US20040033260A1 (en) * 1999-10-19 2004-02-19 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
US9072753B1 (en) * 2000-04-03 2015-07-07 Amy C. Brown Gargle method to reduce the duration of common cold symptoms
US20030215491A1 (en) * 2001-04-30 2003-11-20 Hensley Charles B. Method and composition for rapid delivery of bioactive compounds to the systemic circulation via the nasal membrane
US6929800B2 (en) * 2001-08-06 2005-08-16 Abdul Rasoul Salman Nasal passage cleaning composition
NL1020832C2 (en) * 2002-06-12 2003-12-15 P K Benelux B V Pharmaceutical composition used for nasal administration, useful for strengthening nasal mucosa, comprises water soluble zinc compound
WO2004024225A1 (en) * 2002-09-16 2004-03-25 Zicam, Llc. System and method for delivering a composition to the nasal membrane
US7524517B2 (en) * 2003-01-17 2009-04-28 Uab Research Foundation Methods and compositions for P2X receptor calcium entry channels and other calcium entry mechanisms
US20040180006A1 (en) * 2003-03-12 2004-09-16 Sceusa Nicholas A. Methods and compositions for blocking the calcium cascade
US20070092583A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Cold remedy composition comprising zinc salts
US20090012174A1 (en) * 2004-12-09 2009-01-08 The Dial Corporation Compositions Having a High Antiviral and Antibacterial Efficacy
WO2006062835A2 (en) * 2004-12-09 2006-06-15 The Dial Corporation Compositions having a high antiviral and antibacterial efficacy
MX2007006863A (en) * 2004-12-09 2008-02-25 Dial Corp Compositions having a high antiviral and antibacterial efficacy.
CN101384171A (en) * 2004-12-09 2009-03-11 日晷公司 Compositions having a high antiviral and antibacterial efficacy
MX2007006864A (en) * 2004-12-09 2008-02-15 Dial Corp Compositions having a high antiviral and antibacterial efficacy.
WO2007089267A1 (en) 2006-02-03 2007-08-09 Jr Chem, Llc Anti-aging treatment using copper and zinc compositions
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US20070275929A1 (en) * 2006-05-24 2007-11-29 The Dial Corporation Composition and method for controlling the transmission of noroviruses
CA2653320A1 (en) * 2006-05-26 2008-05-08 The Dial Corporation Method of inhibiting the transmission of viruses
US8034844B2 (en) * 2006-05-30 2011-10-11 The Dial Corporation Compositions having a high antiviral efficacy
US20070281999A1 (en) * 2006-05-31 2007-12-06 The Dial Corporation Alcohol-containing antimicrobial compositions having improved efficacy
EP2034826A2 (en) 2006-06-02 2009-03-18 The Dial Corporation Method of inhibiting the transmission of influenza virus
WO2007145886A2 (en) * 2006-06-05 2007-12-21 The Dial Corporation Methods and articles having a high antiviral and antibacterial efficacy
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US8513420B2 (en) * 2007-03-19 2013-08-20 Monika Mazik Amino-naphthyridine derivatives
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
WO2010085753A1 (en) 2009-01-23 2010-07-29 Jr Chem, Llc Rosacea treatments and kits for performing them
US20150174137A1 (en) * 2010-06-02 2015-06-25 Alcon Research, Ltd. Compositions for treating microbial infections
WO2012048059A2 (en) * 2010-10-06 2012-04-12 Ista Pharmaceuticals, Inc. Bepotastine compositions
BR112013017183A2 (en) 2011-01-04 2017-07-25 Bausch & Lomb bepostatin compositions
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US9611336B2 (en) 2012-10-25 2017-04-04 Baker Hughes Incorporated Quinone compounds for inhibiting monomer polymerization
US9944577B2 (en) 2012-10-25 2018-04-17 Baker Hughes, A Ge Company, Llc Hydroquinone compounds for inhibiting monomer polymerization
US20180147140A1 (en) * 2016-11-30 2018-05-31 Darryl Thomas Finn Treatment and Prevention of ENT Infections

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852432A (en) * 1971-01-18 1974-12-03 Department Of Health Education Diagnostic device and method of treatment
SE393532B (en) * 1974-05-02 1977-05-16 Draco Ab MAKE A PREPARATION OF A PHARMACEUTICAL ZINC PREPARATION FOR THE SUBSTANCE OF A TASTEFUL, PERTAINABLE, PERORAL ZINC SOLUTION CONTAINING A ZINC COMPLEX
US4255419A (en) * 1979-09-27 1981-03-10 Allergan Pharmaceuticals, Inc. Zinc deficiency in multiple sclerosis
US5002970A (en) * 1981-07-31 1991-03-26 Eby Iii George A Flavor masked ionizable zinc compositions for oral absorption
US5409905A (en) * 1981-01-05 1995-04-25 Eby, Iii; George A. Cure for commond cold
US4956385A (en) * 1981-07-31 1990-09-11 Eby Iii George A Method for reducing the duration of the common cold
US4503070A (en) * 1981-07-31 1985-03-05 Eby Iii George A Method for reducing the duration of the common cold
DE3431727A1 (en) * 1984-08-29 1986-03-13 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Nasal spray for coryza and influenza with a content of zinc gluconate
DE3443985A1 (en) * 1984-12-01 1986-06-05 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Pharmaceutical preparations against mycotic and bacterial infections, which contain active ingredients which release zinc in ionised form
US4814164A (en) * 1986-03-10 1989-03-21 Colgate-Palmolive Company Solid antitartar mouth deodorant composition
US4814163A (en) * 1986-03-10 1989-03-21 Colgate-Palmolive Company Solid antitartar mouth deodorant
US4946688A (en) * 1988-07-05 1990-08-07 Fahim Mostafa S Intraprostatic injection of zinc ions for treatment of inflammatory conditions and benign and malignant tumors of the prostate
GB8916625D0 (en) * 1989-07-20 1989-09-06 Bryce Smith Derek Respiratory tract spray preparations

Also Published As

Publication number Publication date
CA2009221C (en) 2000-10-17
DE69024672T2 (en) 1996-08-14
IE71664B1 (en) 1997-02-26
JPH03197430A (en) 1991-08-28
EP0381522A1 (en) 1990-08-08
IE900390L (en) 1990-08-02
DE69024672D1 (en) 1996-02-22
ES2080787T3 (en) 1996-02-16
US5622724A (en) 1997-04-22
GB8902300D0 (en) 1989-03-22
EP0381522B1 (en) 1996-01-10
AU652337B2 (en) 1994-08-25
AU4907290A (en) 1990-08-09
ATE132747T1 (en) 1996-01-15
NZ232356A (en) 1991-10-25

Similar Documents

Publication Publication Date Title
CA2009221A1 (en) Spray preparations for respiratory tract infections
CA2021534A1 (en) Antiallergic spray preparations
CA2146635A1 (en) Concentrated mouthrinse for efficient delivery of antimicrobials
CA2127462A1 (en) Treatment for Asthma
CA2166108A1 (en) Insulin preparations for inhalation
EP0701457A4 (en) Systems for the intrapulmonary delivery of aerosolized aqueous formulations
AU4996793A (en) Dosage inhalator providing optimized compound inhalation trajectory
CA2160366A1 (en) Risperidone pamoate
AU8150087A (en) 3-pyrrolidinylthio-1-azabicyclo (3.2.0)hept-2-ene-2-carboxylic acid compounds and processes for the preparation thereof
GR3002480T3 (en) Condom
AU5317390A (en) Concentrated aqueous solution of glutaraldehyde and 1,2-benzisothiazolin-3-one
CA2145775A1 (en) 1,4-disubstituted piperazines useful in the therapy of the asthma and of the inflammation of the respiratory tract
CA2194549A1 (en) Training projectile
CA2170645A1 (en) Process for the preparation of n-methyl-3-(1-methyl-4-piperidinyl)-14-indole-5-ethanesulphonamide
GR3033745T3 (en) Combination of atovaquone with proguanil for the treatment of protozoal infections.
EP0207505A3 (en) Use of a prenyl ketone in the preparation of a medicament against gastritis
USD269374S (en) Ammonia inhalant package
AU7654094A (en) Microparticles, processes for their preparation and their use for the preparation of medicaments
CA2034926A1 (en) Treatment of poisoning and compositions for use therein
USD282496S (en) Resuscitator for newborn pigs
CA2057456A1 (en) Anti depression pharmaceutical
AU684260B2 (en) 1,4-benzoxazine-2-acetic acid compound, process for producing the same, and use thereof
AU6629590A (en) N-(3',4'-dimethoxycinnamoyl)anthranilic acid
ZA968315B (en) Administration by inhalation of 2-amino-6n-propyl-amino-4,5,,7-tetrahydrobenzothiazole particularly the (-)-enan-tiomer thereof and the pharmacologically acceptable acid addition salts thereof
Odnevall et al. ATMOSPHERIC CORROSION OF ZINC: A MULTI-ANALYTICAL APPROACH

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed